Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
phosphodiesterase inhibitor |
| gptkbp:ATCCode |
C01CE01
|
| gptkbp:CASNumber |
60719-84-8
|
| gptkbp:contraindication |
severe aortic or pulmonic valvular disease
|
| gptkbp:decreasedIn |
systemic vascular resistance
|
| gptkbp:discoveredIn |
1978
|
| gptkbp:eliminationHalfLife |
5-8 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C10H9N3O
|
| https://www.w3.org/2000/01/rdf-schema#label |
amrinone
|
| gptkbp:improves |
cardiac output
cardiac contractility |
| gptkbp:mechanismOfAction |
inhibits phosphodiesterase III
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:arrhythmia
thrombocytopenia liver enzyme elevation |
| gptkbp:synonym |
inamrinone
|
| gptkbp:usedFor |
heart failure
|
| gptkbp:bfsParent |
gptkb:C01CA24
|
| gptkbp:bfsLayer |
7
|